1-4 of 4
Elaine Xiang
Close
Sort by
Journal Articles

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Emily Abdelmessih, Stephanie Wo, David L. Green, Orly Leiva, Elaine Xiang, Tania Ahuja
Journal: Blood
Blood (2023) 142 (Supplement 1): 5122.
https://doi.org/10.1182/blood-2023-187523
Published: 2023
Journal Articles

Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L

Elaine Xiang, Jamie Chin, Jonathan Weltz, Aaron Sango, Meredith Akerman, Michael L. Grossbard, Shella Saint Fleur-Lominy
Journal: Blood
Blood (2022) 140 (Supplement 1): 10806–10807.
https://doi.org/10.1182/blood-2022-167207
Published: 2022
Journal Articles

Evaluating the Safety of Outpatient Ramp up of Venetoclax in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Elaine Xiang, Frank Cirrone, Jamie Chin, Meredith Akerman, Shella Saint Fleur-Lominy, Maher Abdul Hay
Journal: Blood
Blood (2021) 138 (Supplement 1): 2311.
https://doi.org/10.1182/blood-2021-145057
Published: 2021
Journal Articles

Evaluation of Re-Intensification of Daratumumab to Weekly or Biweekly Dosing Schedule

Elaine Xiang, PharmD, Hillary Prescott, PharmD, Jacob Laubach, MD, Paul Richardson, Kaitlen Reyes, NP, Irene M. Ghobrial, MD, Houry Leblebjian, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2024.
https://doi.org/10.1182/blood-2018-99-111191
Published: 2018